PR-Set7 deficiency limits uterine epithelial population growth hampering postnatal gland formation in mice

Tongtong Cui1,2, Bo He1,2, Shuangbo Kong3,4

  • 1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, People's Republic of China.

Insights

The epigenetic regulator PR-Set7 is crucial for endometrial gland formation (adenogenesis) by ensuring sufficient epithelial cell growth. Its absence causes infertility due to DNA damage and cell death, highlighting a potential risk of progesterone therapy.

Area of Science:

  • Reproductive biology
  • Epigenetics
  • Developmental biology

Background:

  • Adenogenesis, the formation of uterine glands, is vital for female fertility.
  • Epigenetic regulation of endometrial gland development remains poorly understood.
  • Impaired adenogenesis is linked to female infertility.

Purpose of the Study:

  • To investigate the role of the epigenetic regulator PR-Set7 in uterine adenogenesis.
  • To elucidate the molecular mechanisms underlying PR-Set7's function in endometrial gland development.
  • To establish a model for successful uterine gland formation.

Main Methods:

  • Conditional deletion of PR-Set7 in mouse uteri.
  • Analysis of epithelial cell proliferation, DNA damage, and apoptosis.
  • Utilized PgrCre/+/Rosa26DTA/+ mouse model and progesterone treatment.
  • Investigated H4K20me1/2 modification and 53BP1 recruitment.

Main Results:

  • PR-Set7 deletion resulted in complete absence of endometrial glands and infertility in mice.
  • PR-Set7 deficiency led to reduced epithelial cell growth, DNA damage, and apoptosis.
  • Reduced H4K20me1/2 levels impaired 53BP1 recruitment to DNA damage sites.
  • Impaired epithelial cell population growth, induced by DTA or progesterone, hampered adenogenesis.

Conclusions:

  • PR-Set7 is essential for maintaining an 'epithelial population growth threshold' required for adenogenesis.
  • Findings reveal a novel epigenetic mechanism governing uterine gland development.
  • Progesterone supplementation for preterm birth may pose a risk to female reproductive development by hindering adenogenesis.

Related Concept Videos